Table of Contents

February 01, 2014; Volume 81, Issue 2

  • From the Editor

      • The impact of anti-TNF therapy on the nonspecialist

        Brian F. Mandell, MD, PhD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 71-72;
        • DOI: https://doi.org/10.3949/ccjm.81b.02014

        • These drugs are being used in a growing number of diseases. We all need to increase our familiarity with their unique risks.

  • The Clinical Picture

      • Slow-growing angiomatous lesions on the limbs

        José Ramón Estela Cubells, MD, Amparo Pérez Ferriols, MD and Víctor Alegre De Miquel, MD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 79-80;
        • DOI: https://doi.org/10.3949/ccjm.81a.13058

        • Erythematous plaques after age 70 should raise the suspicion of classic Kaposi sarcoma.

      • Wide QRS complex rhythm with pulseless electrical activity

        Laszlo Littmann, MD, PhD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 81-82;
        • DOI: https://doi.org/10.3949/ccjm.81a.13079

        • Although this presentation is grave, several of its possible causes can be treated, allowing the patient to recover.

  • 1-Minute Consult

      • Should patients with gout avoid

        Brian F. Mandell, MD, PhD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 83-86;
        • DOI: https://doi.org/10.3949/ccjm.81a.13131

        • No study has directly addressed this issue. In most cases, continue the thiazide and adjust the hypouricemic therapy if necessary.

  • Review

      • Clinical update in sexually transmitted diseases –2014

        Robyn Neblett Fanfair, MD, MPH and Kimberly A. Workowski, MD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 91-101;
        • DOI: https://doi.org/10.3949/ccjm.81a.13090

        • With recent changes to the health care landscape, expect to encounter more patients with STDs.

      • TOC Icon

        Anticoagulation and antiplatelet therapy in acute coronary syndromes

        Dhssraj Singh, MD, Kamal Gupta, MD and James L. Vacek, MD, MSc
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 103-114;
        • DOI: https://doi.org/10.3949/ccjm.81a.13016

        • Antiplatelet and anticoagulant drugs prevent ischemic events but can cause bleeding. Here is how to optimize the benefit.

      • Managing risks of TNF inhibitors: An update for the internist

        Jennifer Hadam, MD, Elie Aoun, MD, MS, Kofi Clarke, MD and Mary Chester Wasko, MD, MSc
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 115-127;
        • DOI: https://doi.org/10.3949/ccjm.81a.12121

        • Tumor necrosis factor inhibitors pose infrequent but serious risks, including infection and malignancy.

  • Departments

      • Stiff, numb hands (June 2013)

        Morton H. Field, MD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87;
        • DOI: https://doi.org/10.3949/ccjm.81c.02001

        • Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

      • In Reply: Stiff, numb hands (June 2013)

        Khaldoon Shaheen, MD and Srinivas Merugu, MD, MMM
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87;
        • DOI: https://doi.org/10.3949/ccjm.81c.02002

        • Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

      • Canagliflozin (November 2013)

        René Rodríguez-Gutiérrez, MD and Gloria Gonzalez-Saldivar, MD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 87-88;
        • DOI: https://doi.org/10.3949/ccjm.81c.02003

        • Readers comment on the measurement of serum calcium in a patient with tetany (June 2013) and on the metabolic side effects of canagliflozin (November 2013).

      • Canagliflozin (November 2013)

        David L. Keller, MD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 88-90;
        • DOI: https://doi.org/10.3949/ccjm.81c.02004

      • In Reply: Canagliflozin (November 2013)

        Mary Vouyiouklis, MD
        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 90;
        • DOI: https://doi.org/10.3949/ccjm.81c.02005

      • Reviewers 2013

        • Cleveland Clinic Journal of Medicine February 2014, 81 (2) 102;
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine

Cleveland Clinic Journal of Medicine

Vol. 81, Issue 2

1 Feb 2014

Table of Contents Table of Contents (PDF) Index by author

Sign up for alerts

Jump to

More...
More...